X0306 4 2018-12-06 0 0001603756 Axonics Modulation Technologies, Inc. AXNX 0001380178 Malik Shahzad 26 TECHNOLOGY DRIVE IRVINE CA 92618 1 0 0 0 Common Stock 2018-12-06 4 A 0 2500 0.00 A 2500 D Common Stock 58234 I By Advent Life Sciences LLP Common Stock 1636115 I By Advent Life Sciences Fund II LP Stock Option (Right to Buy) 14.80 2018-12-06 4 A 0 5000 0.00 A 2028-12-06 Common Stock 5000 5000 D Securities are held by Advent Life Sciences LLP ("Advent"). The reporting person, who is a member of the Issuer's board of directors, is a general partner of Advent, and disclaims beneficial ownership of the shares held by Advent except to the extent of his indirect pecuniary interest therein. Securities are held by Advent Life Sciences Fund II LP. Advent is the general partner of Advent Life Sciences Fund II LP and the reporting person, who is a member of the Issuer's board of directors, is a partner of Advent. The reporting person disclaims beneficial ownership of the shares held by Advent Life Sciences Fund II LP except to the extent of his respective indirect pecuniary interest therein. The shares subject to the option will vest in full on April 30, 2019. /s/ Michael V. Williamson, as Attorney-in-Fact for Shahzad Malik 2018-12-10